We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-3.48%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$85.2B
AUM Growth
+$4.83B
Cap. Flow
+$8.98B
Cap. Flow %
10.54%
Top 10 Hldgs %
12.02%
Holding
4,686
New
822
Increased
1,556
Reduced
1,625
Closed
650

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$786M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$409M
3
MU icon
Micron Technology
MU
+$379M
4
T icon
AT&T
T
+$372M
5
MDT icon
Medtronic
MDT
+$370M

Sector Composition

Rank Sector Weight
1 Healthcare 18.69%
2 Technology 14.95%
3 Consumer Discretionary 11.34%
4 Consumer Staples 10.7%
5 Communication Services 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DSWL icon
3901
Deswell Industries
DSWL
$51.6M
$53K ﹤0.01%
14,600
-6,100
-29% -$23.3K
INBS icon
3902
Intelligent Bio Solutions
INBS
$4.33M
$53K ﹤0.01%
+28
New +$64.4K
BACK
3903
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
$53K ﹤0.01%
1,713
-743
-30% -$25.2K
HYRE
3904
DELISTED
HyreCar Inc. Common Stock
HYRE
$53K ﹤0.01%
22,092
-35,408
-62% -$109K
GNCA
3905
DELISTED
Genocea Biosciences, Inc.
GNCA
$53K ﹤0.01%
42,700
+15,200
+55% +$16.6K
EZGO
3906
EZGO Technologies
EZGO
$2.09M
-1
Closed -$167K
REED
3907
DELISTED
Reeds, Inc. Common Stock
REED
$52K ﹤0.01%
3,471
-2,103
-38% -$32.5K
CRXT
3908
DELISTED
Clarus Therapeutics Holdings, Inc. Common Stock
CRXT
$52K ﹤0.01%
+34,700
New +$44.1K
SLAI
3909
DELISTED
SOLAI Ltd ADS
SLAI
$51K ﹤0.01%
+260
New +$61.1K
CHRN
3910
ChronoScale Holdings
CHRN
$3.2B
$51K ﹤0.01%
1,173
-3,950
-77% -$155K
TAOP icon
3911
Taoping
TAOP
$6.63M
$51K ﹤0.01%
118
-84
-42% -$42.1K
XYLO
3912
DELISTED
Xylo Technologies
XYLO
$51K ﹤0.01%
1,165
-68
-6% -$2.95K
COMS
3913
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
$51K ﹤0.01%
603
-2,467
-80% -$155K
MDNA
3914
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$51K ﹤0.01%
39,700
-59,300
-60% -$92.1K
IFBD icon
3915
Infobird
IFBD
$8.52M
$50K ﹤0.01%
18
-21
-54% -$71.5K
INZY
3916
DELISTED
Inozyme Pharma
INZY
$49K ﹤0.01%
+11,900
New +$70K
NAK
3917
Northern Dynasty Minerals
NAK
$784M
$49K ﹤0.01%
+118,529
New +$42K
SIFY
3918
Sify Technologies
SIFY
$1.06B
$49K ﹤0.01%
2,733
-10,980
-80% -$201K
NAUT icon
3919
Nautilus Biotechnolgy
NAUT
$124M
$48K ﹤0.01%
+11,000
New +$45.2K
YINN icon
3920
Direxion Daily FTSE China Bull 3X ETF
YINN
$782M
$48K ﹤0.01%
515
-1,725
-77% -$251K
KRBP
3921
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$48K ﹤0.01%
+1,870
New +$55.3K
PHGE icon
3922
BiomX
PHGE
$1.99M
$46K ﹤0.01%
126
-276
-69% -$82.1K
PLAG icon
3923
Planet Green Holdings
PLAG
$8.44M
$46K ﹤0.01%
5,119
-4,561
-47% -$41K
XELB icon
3924
Xcel Brands
XELB
$7.27M
$46K ﹤0.01%
3,055
-3,565
-54% -$44.4K
THER
3925
DELISTED
THERATECHNOLOGIES INC COM
THER
$45K ﹤0.01%
18,500
-37,788
-67% -$91.9K

Similar funds

Renaissance Technologies's Q1 2022 Portfolio in Review

As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.

  • Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
  • Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
  • Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
  • Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
  • Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
  • Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.

Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.